The site offers resources and product recommendations to address key needs such as muscle maintenance, micronutrient balance, gut function, hydration, and overall weight management for individuals using GLP1 therapies
Some notice shifts in desire within weeks of starting treatment
By 2026, the landscape includes selective GLP-1 receptor agonists, dual GLP-1/GIP receptor co-agonists, triple receptor agonists targeting GLP-1/GIP/glucagon receptors simultaneously, and the first non-peptide oral small-molecule GLP-1 agonist
The hypothesis is that by combining these two agents, one addresses the systemic hormonal signals that govern eating behavior and macroscopic energy balance, while the other fine- tunes the cellular machinery responsible for metabolic efficiency
SUSTAIN, Semaglutide Unabated Sustainability in Treatment of T2DM
Extended Data Figure 3 Single-particle cryo-EM analysis of the hGLP-1rGLP-1RG s complex